| Basis of Allotment |
| (This is only an advertisement for information purpose and not a prospectus announcement.) |
|
| WALPAR NUTRITIONS LIMITED |
| CIN: U24230GJ2020PLC118662 |
Our Company was originally formed and registered as a partnership firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Walpar Healthcare", pursuant to a deed of partnership dated November 16, 2009. Subsequently, the constitution of partnership firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of partners. "M/s. Walpar Healthcare" was thereafter converted from a partnership firm to a public limited company under Part I chapter XXI of the Companies Act, 2013 in the name of "Walpar Nutritions Limited" and received a certificate of incorporation dated December 4, 2020 from the Central Registration Center, Ministry of Corporate Affairs.
| Registered office: 2nd Floor, L5: 377 PLOT:5, Opp. Sabarmati, Village: Khatraj, Taluka kalol, District: Gandhinagar-382721 |
| Website: www.walparnutritions.com; E-Mail: compliance@walparnutritions.com; Telephone No: +91 2764-662626 |
| Company Secretary and Compliance Officer: Ms. Palakben Mahesh Joshi |
| PROMOTERS OF THE COMPANY: MR. KALPESH PRAVINCHANDRA LADHAWALA, MR. TANMAYKUMAR ASHWINBHAI SHAH AND MRS. SEJAL KALPESH LADHAWALA |
| BASIS OF ALLOTMENT SME IPO (NSE EMERGE) |
PUBLIC ISSUE OF 1200000 EQUITY SHARES OF FACE VALUE OF Rs. 10 EACH OF WALPAR NUTRITIONS LIMITED ("WALPAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF Rs. 55 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 45 PER EQUITY SHARE (THE "ISSUE PRICE") AGGREGATING TO Rs. 660.00 LAKH ("THE ISSUE"), OF WHICH 60000 EQUITY SHARES OF FACE VALUE OFRs. 10 EACH FOR CASH AT A PRICE OFRs. 55 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 45 PER EQUITY SHARE AGGREGATING TO Rs. 33.00 LAKH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERTO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION i.e. NET ISSUE OF 1140000 EQUITY SHARES OF FACE VALUE OF Rs. 10 EACH AT A PRICE OF Rs. 55 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF Rs. 45 PER EQUITY SHARE AGGREGATING TO Rs. 627.00 LAKH IS HEREIN AFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 26.42% AND 25.10% RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
In terms of the Prospectus dated June 15, 2021 and as per 253(2) of the SEBI (ICDR) Regulations, 2018 wherein allocation In the net offer to the public category shall be; (a) minimum of 50 % to Retail Individual Investors and (b) remaining to i) individual applicants other than retail individual investors and ii) other investors including corporate bodies or institutions, irrespective of number of specified securities applied for, Provided that the unsubscribed portion in either of the categories specified in clauses (a) or (b) may be allocated to applicants in the other category.
Explanation: If the retail individual investor category is entitled to more than fifty per cent, of the Net issue size on a proportionate basis, the retail individual investors shall be allocatedthathigher percentage.
| THE FACE VALUE OF THE EQUITY SHARES IS Rs. 10/- EACH AND |
| THE ISSUE PRICE IS Rs. 55/- EACH INCLUDING A SHARE PREMIUM OF Rs. 45/- PER EQUITY SHARE. |
| THE ISSUE PRICE IS 5.5 TIMES OFTHE FACE VALUE. |
| ISSUE WAS OPENED ON WEDNESDAY, JUNE 30,2021 AND |
| CLOSED ON MONDAY, JULY 05, 2021. |
The Equity Shares offered through the Prospectus are proposed to be listed on Emerge Platform of National Stock Exchange of India Ltd. (NSE) In terms of the Chapter IX of the SEBI (ICDR) Regulations, 2018, as amended from time to time, our Company has received in principle approval letter dated June 09, 2021 from NSE for using its name in this offer document or listing our shares on the Emerge Platform of NSE. For the purpose of this Issue, the designated Stock Exchange will be the NSE.
Details of Applications: The Issue has received 2657 applications (before Technical Rejections but after removing 3557 applications for 71,72,000 shares for which "bid filed but not banked) for 57,30,000 Equity Shares (Including Market Maker Application of 60000 Equity Shares) resulting 4.7750 times subscription. The details of the valid applications received in the Issue (after Technical Rejections and after removing 3557 applications for 71,72,000 shares for which "bid filed but not banked) are as follows:
Details of the valid Applications Received (after Technical Rejections and after removing 3557 applications for 71,72,000 shares for which "bid filed but not banked):
| No. | Category | Number of Applications | Number of Equity Shares | Subscription Ratio |
| 1 | Market Makers | 1 | 60,000 | 1.0000 Time |
| 2 | Non Retail Investor's | 45 | 4,38,000 | 0.7684 Times |
| 3 | Retail Individual Investor's | 2540 | 50,80,000 | 7.2365 Times* |
| Total | 2586 | 55,78,000 | Overall 4.6483 Times |
Total 71 applications for 1,52,000 shares in Retail Individual Investors and Other than Retail Individual Investors Category were rejected on technical grounds. Further, there was no withdrawal of application in any of the category.
* After Spill-over from other than retail category to the extent of 132000 Equity Shares. (Original Allocation was for 570000 Equity Shares and allotment was made for 702000 Equity Shares)
ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange NSE on July 08,2021.
A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 55/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.0000 time. The total number of shares allotted in this category is 60,000 Equity shares in full, out of reserved portion of 60,000 Equity Shares.
B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal, if any): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs. 55/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 7.2365 times (after technical rejection and Spill-over from other than retail category). Total number of shares allotted in this category is 7,02,000 Equity Share as under;
| No. of Shares Applied for (Category wise) | No. of Applications received | % to total | Total No. of Equity Shares applied | % of total | Proportionate Shares Available | Allocation per Applicant (Before Rounding Off | Allocation per Applicant (After Rounding Off) | Ratio of Allottees to the Applicants | Serial Number of Qualifying applicants | Number of Successful Applicants (After Rounding Off) | % to Total | Total No. of Equity Shares allocated1' allotted | % to Total | Surplus/ (Deficit) |
| 2000 | 2540 | 100.00 | 5080000 | 100.00 | 702000 | 276.37 | 2000 | 3512540 | As below | 351 | 100.00 | 702000 | 100.00 | 0 |
| Total | 2540 | 100.00 | 5080000 | 100.00 | 702 0 00 | 351 | 100.00 | 702000 | 100.00 | 0 |
Serial Number of Qualifying applicants -Retail Individual Investors;
8, 15, 23, 26, 29, 34, 36, 39, 44, 51, 53, 54, 55, 60, 73, 77, 80, 91, 92, 93, 111, 126, 128, 146, 153, 163, 165, 168, 178, 185, 194, 198, 214, 215, 236, 249, 251, 264, 266, 269, 306, 309, 311, 344, 356, 360, 368, 375, 378, 381, 382, 390, 400, 407, 419, 421, 429, 431, 434, 438, 441, 442, 445, 450, 454, 466, 469, 473, 479, 484, 489, 493, 495, 498, 513, 518, 526, 533, 536, 539, 552, 554, 563, 566, 568, 570, 581, 589, 590, 591, 593, 606, 611, 612, 613, 616, 619, 621, 627, 632, 634, 648, 654, 656, 665, 674, 677, 685, 687, 700, 708, 715, 716, 718, 723, 755, 758, 776, 777, 790, 819, 822, 827, 836, 837, 838, 841, 848, 854, 864, 875, 878, 888, 895, 904, 924, 942, 950, 959, 962, 963, 964, 970, 974, 976, 1009, 1014, 1019, 1026, 1027, 1029, 1030, 1053, 1059, 1061, 1066, 1080, 1086, 1087, 1101, 1102, 1109, 1110, 1113, 1115, 1117, 1118, 1119, 1130, 1137, 1143, 1162, 1164, 1168, 1169, 1176, 1181, 1186, 1200, 1205, 1207, 1217, 1220, 1236, 1239, 1240, 1246, 1257, 1259, 1263, 1265, 1267, 1271, 1273, 1276, 1282, 1308, 1318, 1341, 1343, 1352, 1354, 1358, 1359, 1360, 1366, 1390, 1404, 1406, 1429, 1435, 1444, 1445, 1451, 1452, 1455, 1464, 1477, 1483, 1496, 1501, 1515, 1521, 1525, 1530, 1539, 1550, 1562, 1567, 1570, 1572, 1577, 1582, 1600, 1659, 1669, 1672, 1676, 1698, 1718, 1720, 1724, 1773, 1787, 1807, 1819, 1821, 1825, 1828, 1831, 1835, 1839, 1845, 1853, 1863, 1870, 1874, 1877, 1879, 1882, 1896, 1898, 1920, 1929, 1944, 1947, 1949, 1960, 1968, 1981, 1997, 2000, 2003, 2014, 2018, 2033, 2045, 2047, 2054, 2056, 2058, 2062, 2072, 2080, 2081, 2083, 2086, 2088, 2092, 2101, 2106, 2107, 2108, 2110, 2115, 2126, 2155, 2162, 2167, 2168, 2173, 2183, 2190, 2201, 2209, 2223, 2233, 2234, 2255, 2258, 2273, 2279, 2280, 2286, 2307, 2309, 2314, 2318, 2343, 2344, 2345, 2350, 2353, 2354, 2378, 2385, 2392, 2401, 2404, 2410, 2413, 2421, 2424, 2438, 2439, 2441, 2442, 2456, 2459, 2461, 2467, 2468, 2472, 2494, 2495, 2503, 2508, 2509, 2524, 2526, 2540
c. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs. 55/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 0.7684 times. Total number of shares allotted in this category is 438000 Equity Shares. The category wise basis of allotment is as under:
| No. of Shares Applied for (Category wise) | No. of Applications received | % to total | Total No. of Equity Shares applied | % of total | Proportionate Shares Available | Allocator per Applicant (Before Rounding Off | Allocation per Applicant (After Rounding Off) | Ratio of Allottees to the Applicant | Serial Number of Qualifying applicants | Number o Successful Applicant (After Rounding Off) | % to Total | Total No. of Equity Shares allocated; allotted | % to Total | Surplus/ (Deficit) |
| 4000 | 30 | 66.67 | 120000 | 27.40 | 156164 | 5205.47 | 4000 | 1:1 | 66.67 | 120000 | 27.40 | -36164 | ||
| 6000 | 4 | 8.89 | 24000 | 5.48 | 31233 | 7808.21 | 6000 | 1:1 | 8.89 | 24000 | 5.48 | -7233 | ||
| 8000 | 4 | 8.89 | 32000 | 7.31 | 41644 | 10410.95 | 8000 | 1:1 | 4 | 8.89 | 32000 | 7.31 | -9644 | |
| 10000 | 5 | 11.11 | 50000 | 11.41 | 65069 | 13013.69 | 10000 | 1:1 | Firm Allotment | 5 | 11.11 | 50000 | 11.41 | -15069 |
| 30000 | 1 | 2.22 | 30000 | 6.85 | 39041 | 39041.09 | 30000 | 1:1 | 1 | 2.22 | 30000 | 6.85 | -9041 | |
| 182000 | 1 | 2.22 | 182000 | 41.55 | 236849 | 236849.3 | 182000 | 1:1 | 1 | 2.22 | 182000 | 41.55 | -54849 | |
| Total | 45 | 100.00 | 438000 | 100.00 | 570000 | 45 | 100.00 | 438000 | 100.00 | -132000 |
The Board of Directors of the Company at its meeting held on July 08, 2021 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange viz, NSE and has authorized the corporate action for allotment of shares in dematerialized form to various successful applicants.
The allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories. Further, the instructions to Self-Certified Syndicate Banks were being processed on or before July 09, 2021. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the Emerge Platform of NSE within Six working days from the date of the closure of the Issue. The trading is proposed to be commenced on Tuesday, July 13, 2021 subject to receipt of final listing and trading approvals from the NSE.
INVESTORS PLEASE NOTE
The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Skyline Financial Services Private Limited at www.skylinerta.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:
| SKYLINE FINANCIAL SERVICES PRIVATE LIMITED (CIN: U74899DL1995PTC071324) | On behalf of the Board of Directors |
| Address: D-153A, 1st Floor, Okhla Industrial Area Phase-I, New Delhi - 110020, India. | For, Walpar Nutritions Limited |
| Tel. Number: +91 -11-40450193-97 Fax- +91-11-26812682 Email Id: compliances@skylinerta.com | Sd/- |
| Investors Grievance Id: grievances@skylinerta.com Website: www.skylinerta.com | |
| Contact Person: Ms. Sarita Singh | Kalpesh Pravinchandra Ladhawala |
| Date: July 9, 2021 | Chairman cum Managing Director |
| Place: Gandhinagar | DIN: 02849232 |
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF WALPAR NUTRITIONS LIMITED.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.
|
Close
|